FDA warning letter · Drugs

Seema International

Issued · Posted by FDA

Selected passages from the FDA letter

Quoted FDA text from the published dataset. These selected excerpts are not the complete letter.

Passage 1

Failure to clean equipment and utensils to prevent contamination or carry-over of a material that would alter the quality of the API beyond the official or other established specifications.

Passage 2

Your firm failed to clean separation equipment **(b)(4)** used for the repackaging and relabeling of your **(b)(4)** API. This is also a repeat deviation from a previous inspection.

Passage 3

Failure to design a documented, ongoing stability testing program to monitor the stability characteristics of APIs and to use the results to confirm appropriate storage conditions and retest of expiry dates.

Passage 4

Failure of your quality unit to exercise its responsibility to ensure the APIs manufactured at your facility are in compliance with CGMP.